{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEPO-20203 Pharmacy Procurement of Medicines Policy 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "Pharmacy Procurement of Medicines Policy"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEPO20203"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All pharmacy staff involved in the procurement of medication on behalf of the Trust"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "rd 3 March 2020"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "nd2 March 2023"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "NHS England (2019): A Guide to Managing Medicines Supply and Shortages RPS (2018): Professional Guidance on the safe and secure handling of medicines"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "Regulation 12 safe care and treatment"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "MSE Group Functions: Pharmacy"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "James Kent - Regional Procurement Pharmacist John Southall - Senior Purchasing Technician (SUH)"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "Mid Essex Hospital Services NHS Trust (MEHT) \uf0fcBasildon and Thurrock University Hospitals NHS Foundation Trust (BTUH) Southend University Hospital NHS Foundation Trust (SUHT)"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Medicines Management Committee (SUH/BTUH) Medicines Optimisation and Safety Group (MEH)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "31/01/2020 07/02/2020"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Simon Worrall \u2013 Acting Chief Pharmacist"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "07/02/2020"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "18/02/2020"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group"
                    },
                    {
                        "text": "Date: February 2020"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "Trust Intranet/ Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSEPO-20203 Pharmacy Procurement of Medicines Policy 1.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 8,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Consulted With: this must include Pharmacy if the document has any reference to medication"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Simon Worrall"
                    },
                    {
                        "text": "Acting Chief Pharmacist"
                    },
                    {
                        "text": "13/12/19"
                    },
                    {
                        "text": "Luke Tyler"
                    },
                    {
                        "text": "Chief Pharmacy Purchasing & Distribution Manager (BTUH)"
                    },
                    {
                        "text": "13/12/19"
                    },
                    {
                        "text": "Richard Dixon-Ramsey"
                    },
                    {
                        "text": "Pharmacy Procurement Manager (MEHT)"
                    },
                    {
                        "text": "13/12/19"
                    },
                    {
                        "text": "Anna Man"
                    },
                    {
                        "text": "Lead Pharmacist for Clinical and Cardiothoracic Services (BTUH)"
                    },
                    {
                        "text": "20/12/19"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 1,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "All Medicines Management Policies on all sites and specifically: MSBPO-18021 MM Policy for Pharmacy Purchasing of Medicines via Homecare MSBPO-18017 Unlicensed Medicines Policy All Pharmacy Departmental procedures for procurement on all sites"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 8,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History: Summary of amendments/ Record documents superseded by: Issue Date: Authored/Reviewer: Version No:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "James Kent / John Southall"
                    },
                    {
                        "text": "Replaces Policy MMP040 Policy for Pharmacy Purchasing of Medicines & MMP043 Policy for the Management of Medicine Shortages (SUHT). New policy for BTUH and MEHT. Reviewed in line with NHS England guidance and for mse-wide use"
                    },
                    {
                        "text": "3rd March 2020"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 7
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................. 4"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions ................................................................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Roles and Responsibilities ........................................................................................ 6"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Departmental Structure .............................................................................................. 8"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Adherence to regulatory and professional requirements ....................................... 8"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "General Principles .................................................................................................... 10"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Procurement Processes ........................................................................................... 11"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Medication error/risk reporting systems ................................................................ 16 10 Shortages .................................................................................................................. 16 11 New Product Process (Formulary management etc.) ............................................ 17 12 Change Management Process ................................................................................. 17 13 Unlicensed Medicines .............................................................................................. 18 14 Monitoring and Review ............................................................................................ 19 15 Training Requirements ............................................................................................. 21 16 Monitoring and Audit ................................................................................................ 21 17 Approval and Implementation ................................................................................. 22 18 References ................................................................................................................ 22 19 Equality Impact Assessment ................................................................................... 22 Appendix 1: Purchasing for Safety Decision Making Tree ........................................... 24 Appendix 2: Medication Error, incident and defect reporting systems ...................... 25 Appendix 3: Preliminary Equality Analysis ................................................................... 26"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "The Trust is a public body and therefore publicly accountable."
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "All NHS pharmacy staff assume a duty of care when supplying a medicine. In order to reduce the number/frequency of incidents caused by medication errors it is essential that all risks are identified and assessed. Following risk identification and assessment, action must be taken to minimise the possibility of a patient safety incident."
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "This policy is required to ensure that medicine supply and procurement activities within the Trust are carried out in accordance with the principles of achieving best value for money for all its non-pay expenditure."
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.4,
                "text": "This policy sets out the broad parameters within which the site Pharmacy Procurement Departments will manage their procurement activities in support of the Trust's overall strategic objectives."
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.5,
                "text": "SOPs or work instructions cover the scope of activity of the procurement, receipt, storage and distribution of medicines that falls under the remit of the local pharmacy procurement teams."
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.6,
                "text": "Good procurement practice is critical and procurement decisions are made with due consideration to:"
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Whole life costs;"
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Risk management;"
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Purchasing for safety;"
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Clinical effectiveness;"
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Total supply chain costs / routes;"
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Competition;"
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Stock holding;"
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Environmental impact;"
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Sustainability;"
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Trust policies and strategies / procedures;"
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Legal requirements."
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "The purpose of this document is to:"
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Provide a consistent approach across the three MSE sites to the safe and timely procurement of medicines, which ensures the timely provision of medication for patient use and that relevant legislation and government guidance is adhered to."
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Achieve best value for money for all areas of non-pay expenditure whilst continuing to maintain minimal risk and to provide high quality services to patients."
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure that the Trust operates within a statutory framework by adopting standing orders and standing financial instructions."
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure that all the Trust's business transactions are conducted in accordance with European and English law and government policy."
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure that all medicine expenditure is subject to best procurement practice in order to maximise value for money."
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure that business is conducted and managed in a way that will deliver greater efficiency in the use of resources in a way which ensures probity is"
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 0,
                "text": "maintained."
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "type": "table",
            "sequence_num": 45,
            "data": {
                "num_rows": 19,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "BCP"
                    },
                    {
                        "text": "Business Continuity Plan - A business continuity plan is a roadmap for continuing operations under adverse conditions"
                    },
                    {
                        "text": "CMU"
                    },
                    {
                        "text": "Commercial Medicines Unit. This unit organises the contracting of medicines on behalf of secondary care NHS Trusts"
                    },
                    {
                        "text": "E-commerce"
                    },
                    {
                        "text": "A method of sending and receiving orders and invoices electronically"
                    },
                    {
                        "text": "EoE"
                    },
                    {
                        "text": "East of England NHS region."
                    },
                    {
                        "text": "GDP"
                    },
                    {
                        "text": "Good distribution practice"
                    },
                    {
                        "text": "GHX"
                    },
                    {
                        "text": "NHS Pharmacy Exchange"
                    },
                    {
                        "text": "Homecare"
                    },
                    {
                        "text": "An outsourced service that provides dispensed medicines directly into the patient's home setting"
                    },
                    {
                        "text": "JAC or Ascribe"
                    },
                    {
                        "text": "The pharmacy computer based stock control and dispensing systems. For SUH JAC is also used as the ePrescribing system."
                    },
                    {
                        "text": "KPI's"
                    },
                    {
                        "text": "Key performance indicators"
                    },
                    {
                        "text": "MHRA"
                    },
                    {
                        "text": "Medicines and Health Regulatory Authority. The Medicines and Healthcare products Regulatory Agency (MHRA) is the government agency which is responsible for ensuring that medicines and medical devices work, and are acceptably safe."
                    },
                    {
                        "text": "MOC (or equivalent)"
                    },
                    {
                        "text": "Medicines Optimisation Committee. The Trust body that approves requests for inclusion of medicines onto the Trust's medicines formulary."
                    },
                    {
                        "text": "PAS"
                    },
                    {
                        "text": "Patient Access Scheme"
                    },
                    {
                        "text": "Pharmacy QA"
                    },
                    {
                        "text": "Pharmacy Quality Assurance department (SUH hosted)"
                    },
                    {
                        "text": "PQA"
                    },
                    {
                        "text": "Pharmaceutical Quality Assessment"
                    },
                    {
                        "text": "SFI"
                    },
                    {
                        "text": "Standing Financial Instructions"
                    },
                    {
                        "text": "SLA"
                    },
                    {
                        "text": "Service Level Agreement \u2013 Part of a service contract where a service is formally defined"
                    },
                    {
                        "text": "The Trust"
                    },
                    {
                        "text": "Refers to all of the Trusts within the MSE group of hospitals: Southend University Hospital NHS Foundation Trust Mid Essex Hospitals NHS Trust Basildon & Thurrock University Hospitals NHS Foundation Trust"
                    },
                    {
                        "text": "Unlicensed medicines"
                    },
                    {
                        "text": "Medicines that do not possess a UK Product License or EU Marketing Authorisation. Unlicensed medicines can be grouped as 'specials' - unlicensed medicines which are obtainable from UK commercial suppliers or from NHS pharmaceutical manufacturing units , under a"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 46,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "manufacturer's license (specials) issued by the MHRA or medicines licensed for use and prepared commercially in other countries but which are not licensed for use in the UK"
                    },
                    {
                        "text": "WDA"
                    },
                    {
                        "text": "Wholesale distribution authorisation"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Roles and Responsibilities"
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "Role & Responsibilities within the Trust (Committees)  Duties Are:"
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 1,
                "text": "4.1.1 Medicines Optimisation Committee (or equivalent) (group-wide)"
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Escalating any medicines procurement issues, as relevant to the Clinical Governance Committee (or equivalent)."
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Approving requests for medicines to be added to the hospital medicines formulary."
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 1,
                "text": "4.1.2 Pharmacy Directorate Board (PB) (group-wide is responsible for taking action with respect to pharmacy service delivery."
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 1,
                "text": "4.1.3 Directorate of Pharmacy"
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Safe and effective procurement of all medicines to be used in the Trust."
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Stock of medicines held in the pharmacy, their manipulation and preparation into ready to use presentations and for their supply to wards and departments."
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "Roles & Responsibilities Role & Responsibilities of Individuals within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Duties Are:"
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 1,
                "text": "4.2.1 Chief Pharmacist (Director of Pharmacy) (group-wide)"
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Establishing and maintaining a system for the secure and safe handling of medicines in consultation with the appropriate medical, nursing, allied health professional and administrative staff."
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Establishing and maintaining a system for the procurement of medicines that is safe, effective and representative for optimal value for money."
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 1,
                "text": "4.2.2 Site Pharmacy Head of Department"
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 0,
                "text": "As the Trust's named accountable officer for controlled drugs they are responsible for ensuring that effective controls are in place, including safe and secure procurement."
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure that the system for the procurement of medicines on site is operating effectively."
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 1,
                "text": "4.2.3 Pharmacist in Charge / Chief Technician for Operations"
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The pharmacy department on each site is divided into key areas led by a Pharmacist in Charge or Chief Technician. Each lead works under the Director of Pharmacy and site Head of Department providing management support and is responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Operations Services \u2013Dispensary, supply of medicines"
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Clinical Services \u2013 Clinical and ward-based pharmacy, formulary and medicines governance"
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Quality Systems \u2013 Quality assurance of all aspects of medicines management"
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Technical Services \u2013 Sterile production, chemotherapy manufacture, pre- packing of medicines."
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.2.3.1 Each service lead is responsible for ensuring issues concerning procurement of medicines for their service are escalated and managed efficiently and effectively with the pharmacy procurement team."
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 1,
                "text": "4.2.4 Regional Procurement Specialist Pharmacist"
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Co-ordinating the medicines procurement approach on a regional level."
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring a continual dialogue between the Trust and pharmaceutical manufacturers."
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Representing the interests of all site pharmacy procurement departments at a regional and national level."
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 1,
                "text": "4.2.5 Site Pharmacy Operations Manager"
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that medicine control systems and procedures are followed at all times."
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring all staff working with medicines in the specified area have the required qualifications and competencies."
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reporting any risks or incidents in relation to non-compliance with procurement of medicines"
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Site leadership to the procurement team, supporting the site Head of Department."
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 1,
                "text": "4.2.6 Site Lead Pharmacy Procurement Technician Responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Exercising professional judgement when procuring and supplying medicines."
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that contracts and local price agreements are adhered to."
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Maintaining the contract database within JAC/Ascribe."
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Managing medicine supply problems, ensuring that medicines are available when needed."
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that order processes are efficient and cost effective."
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the timely processing of all Homecare prescriptions."
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the processing and passing of invoices for payment."
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Assuring the appropriate release of all authorised purchase orders for medicines."
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Providing reports and analysis on procurement activities within pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Departmental Structure"
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "A clearly described staffing structure for those working within the pharmacy procurement department is present for all sites."
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "An organogram is in place indicating the key relationships both inside and outside the procurement department; this would also define the chain of command between the lead pharmacy procurement technician at each site and the group Chief Pharmacist."
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Adherence to Regulatory and Professional Requirements"
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "All procurement staff operate in accordance with all relevant regulatory and professional requirements."
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.2,
                "text": "Standing Financial Instructions (SFIs)"
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.2.1 The Trust SFIs detail the financial responsibilities, policies and procedures to be adopted by the Trust. They are designed to ensure that its financial transactions are carried out in accordance with the law and government policy in order to achieve probity, accuracy, economy, efficiency and effectiveness."
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.2.2 Any procurement of medicines undertaken by the pharmacy procurement team strictly adheres to Trust SFIs. Items with an annual purchase value greater than Trust SFI or EU thresholds are tendered for, unless there is good reason."
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.3,
                "text": "Safe and Secure Handling of Medicines"
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.3.1 This good practice guidance covers obtaining medicines, their transport, receipt, manufacture or manipulation and storage. It also includes information on the issuing of medicines, and their removal or disposal."
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.3.2 The Trust also ensures it complies with any legal requirements in place that relate to the procurement, storage and distribution of medicines. This will include licensed medicines, parallel imports, unlicensed medicines and clinical trial materials."
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.4,
                "text": "Wholesaler Dealers License"
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.4.1 For a pharmacy to sell or supply medicines to anyone other than the patient, there is a need for a wholesaler licence \u2013 also known as a wholesale dealer licence or wholesale distribution authorisation (WDA)."
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.4.2 To qualify for, and maintain, a wholesale licence, sites must comply with good distribution practice (GDP) and pass regular GDP inspections on site."
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.5,
                "text": "Good Distribution Practice"
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.5.1 GDP describes the minimum standards that a wholesale distributor must meet to ensure that the quality and integrity of medicines is maintained throughout the supply chain."
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.5.2 GDP compliance ensures that:"
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Medicines in the supply chain are authorised in accordance with European Union legislation (and any post-Brexit equivalent legislation);"
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Medicines are stored in the right conditions at all times, including during transportation;"
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Contamination by, or of, other products is avoided;"
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 0,
                "text": "An adequate turnover of stored medicines takes place;"
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The right products reach the right addressee within a satisfactory time period."
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.6,
                "text": "Contracting for Medicines"
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.6.1 The CMU puts framework agreements in place to enable the NHS in secondary care in England to purchase licensed medicines within the EU procurement regulations. These contracts should be utilised wherever possible."
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.6.2 The CMU will oversee the NHS drug tendering process for national and regional contracts."
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.6.3 Compliance with CMU contracts is monitored and purchase of lines at non- contract prices (higher or lower) should be avoided unless the required item is subject to a supply disruption."
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.6.4 There should be a local system in place to ensure continuing adherence to local and other medicines contracts which also monitors prices for appropriateness."
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.7,
                "text": "EU Procurement Law"
            },
            "type": "ListItem",
            "sequence_num": 123
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.7.1 Procurement of medicines by an NHS Trust is subject to EU procurement legislation. In some cases individual hospitals may need to purchase a medicine for which has not been tendered by the CMU."
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.7.2 In these instances, it is imperative that this purchase is undertaken in a way that complies with relevant EU legislation and with local SFIs. This will remain in place until any replacement legislation is implemented post-Brexit."
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.8,
                "text": "Responsible, Ethical, Professional"
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.8.1 All NHS staff should uphold the 7 Principles of Public Life (2)."
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.8.2 This is particularly true of staff involved in the procurement of medicines due to the costs associated with the medicines they procure and the potential pressure and scrutiny this places them under."
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.8.3 Conflicts of interest must always be made public."
            },
            "type": "ListItem",
            "sequence_num": 129
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.8.4 Declarations of interest must be appropriately recorded and the confidentiality of the pricing and contracts in place always respected."
            },
            "type": "ListItem",
            "sequence_num": 130
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.9,
                "text": "There is a programme of training and awareness for all pharmacy procurement staff in relation to these issues."
            },
            "type": "ListItem",
            "sequence_num": 131
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "General Principles"
            },
            "type": "ListItem",
            "sequence_num": 132
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "The pharmacy department is responsible for ensuring that medicines management systems are efficient and robust."
            },
            "type": "ListItem",
            "sequence_num": 133
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "Systems are in place to reduce the risk of medication errors (prescribing, ordering, dispensing, labelling, supply and administration)."
            },
            "type": "ListItem",
            "sequence_num": 134
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.3,
                "text": "The local pharmacy procurement teams ensure that the processes surrounding the purchase of medicines are set up to deliver this function in the most safe and effective way possible."
            },
            "type": "ListItem",
            "sequence_num": 135
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.4,
                "text": "Procurement of medicines for the Trust is undertaken only by persons authorised to do so."
            },
            "type": "ListItem",
            "sequence_num": 136
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.5,
                "text": "The pharmacy procurement purchasing department only purchases from a specified range of medicines, reflecting current use and the Trust's medicine formulary as approved by the Trust's Medicine Optimisation Committee (MOC), or equivalent. The formulary is accessible via the Trust intranet site. A version of this document is available to patients on each hospital's official website."
            },
            "type": "ListItem",
            "sequence_num": 137
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.6,
                "text": "All medicines purchased for the Trust are done so using the local pharmacy computer system (e.g. JAC or Ascribe) and is undertaken in accordance with this policy."
            },
            "type": "ListItem",
            "sequence_num": 138
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.7,
                "text": "All medicines are purchased from trusted supply sources to ensure their suitability and to minimise the possibility of counterfeit medicines. Trusted sources are any MHRA approved manufacturer, distributor, wholesaler or importer that has also been approved by pharmacy QA."
            },
            "type": "ListItem",
            "sequence_num": 139
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.8,
                "text": "Requests to source non-MOC (or equivalent committee) approved medicines must first be approved by the site Clinical Lead Pharmacist or their deputy and the required document relating to new drug/non-formulary medicines must be completed (e.g. \u2018Internal request for drug not on JAC form' or equivalent) and submitted to the Clinical lead Pharmacist or their deputy for authorisation."
            },
            "type": "ListItem",
            "sequence_num": 140
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.9,
                "text": "The pharmacy procurement department ensures that wherever possible, orders for medicines are placed for products contracted by the CMU."
            },
            "type": "ListItem",
            "sequence_num": 141
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "Safe and secure methods of procurement (e.g. e-commerce) are utilised to minimise the potential for error during the ordering."
            },
            "type": "ListItem",
            "sequence_num": 142
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.11,
                "text": "The successful functioning of the pharmacy procurement team relies upon the support and cooperation of all other elements of the pharmacy department. This needs to be underpinned by robust two-way communication systems to ensure that management of key issues (e.g. ongoing shortages, review of new drug requests) is optimised and that relevant staff are kept informed of key developments."
            },
            "type": "ListItem",
            "sequence_num": 143
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Procurement Processes"
            },
            "type": "ListItem",
            "sequence_num": 144
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.1,
                "text": "Procurement"
            },
            "type": "ListItem",
            "sequence_num": 145
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.1.1 All ordering of drugs is undertaken against a valid (signed) order and is transmitted to suppliers in one of the following ways:"
            },
            "type": "ListItem",
            "sequence_num": 146
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Electronic (EDI)"
            },
            "type": "ListItem",
            "sequence_num": 147
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Email where suppliers are not on GHX"
            },
            "type": "ListItem",
            "sequence_num": 148
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Fax / e-Fax (fax is being phased out by April 2020)"
            },
            "type": "ListItem",
            "sequence_num": 149
        },
        {
            "data": {
                "is_heading": 0,
                "text": "By telephone."
            },
            "type": "ListItem",
            "sequence_num": 150
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.1.2 Wherever possible, e-commerce using NHS Pharmacy Exchange (GHX) is the preferred means of order transmission and invoice / credit processing in order to minimise the potential for error in the ordering process. Orders placed electronically should feed directly into the supplier's stock control system rather than requiring further manual key re-entry."
            },
            "type": "ListItem",
            "sequence_num": 151
        },
        {
            "data": {
                "is_heading": 1,
                "text": "8.1.3 The ability to communicate in this way with suppliers should be reviewed regularly to ensure all opportunities to trade in this way are taken up. Telephone orders are used as a last resort or in an emergency."
            },
            "type": "ListItem",
            "sequence_num": 152
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.1.4 All drugs are purchased from trusted and appropriate sources of supply, to ensure their suitability, and to minimise the possibility of counterfeit medicines."
            },
            "type": "ListItem",
            "sequence_num": 153
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.1.5 Where possible medicines are purchased against a national (i.e. CMU) or regional (EoE Collaborative Procurement Hub) contract. Nationally tendered medicines will have undergone a risk assessment process with subsequent allocation of a Pharmaceutical Quality Assessment (PQA) score (low, medium, high). High PQA score products, where awarded, will need to be reviewed locally to ensure any required risk mitigation can take place."
            },
            "type": "ListItem",
            "sequence_num": 154
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.1.6 Any changes to a medicine's contract price, supply route, product description or contract termination date are processed on JAC/Ascribe as soon after notification from CMU as possible so as to maintain accurate real time catalogues, ensure cost effective procurement and reflect correct pricing of contracted medicines at all times; including Patient Access Scheme (PAS) prices."
            },
            "type": "ListItem",
            "sequence_num": 155
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.1.7 Trusted sources are any MHRA approved wholesaler, manufacturer, distributor, CMU contracted supplier or homecare provider. Suppliers that are unknown to the procurement team are subject to QA approval. Concerns relating to the holding of appropriate licenses should be referred to the CMU where a contract is in place."
            },
            "type": "ListItem",
            "sequence_num": 156
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.1.8 Orders for drugs are generated on the pharmacy procurement system either triggered by the breach of a pre-defined stock minimum, or by the raising of an order manually."
            },
            "type": "ListItem",
            "sequence_num": 157
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.1.9 All pharmacy orders are vetted to ensure that the correct drug has been ordered from the correct supplier and in the appropriate quantity. For each of the various types of medication that need to be ordered, there is an ordering procedure in place."
            },
            "type": "ListItem",
            "sequence_num": 158
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.1.10 Vetted orders are overseen by the site Lead Pharmacy Procurement Technician, or their deputy, prior to release to suppliers that will fall into one of the following main categories."
            },
            "type": "ListItem",
            "sequence_num": 159
        },
        {
            "data": {
                "is_heading": 1,
                "text": "a) Wholesalers"
            },
            "type": "ListItem",
            "sequence_num": 160
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Orders placed with wholesalers are vetted and released twice a day. Morning orders will be delivered on the same day and afternoon orders will be delivered the following morning."
            },
            "type": "ListItem",
            "sequence_num": 161
        },
        {
            "data": {
                "is_heading": 0,
                "text": "High volume (low value) or low volume (high value) lines are assigned to a frequent (weekly) re-order process on the pharmacy system (e.g. JAC/Ascribe) to avoid overstocking (volume & value)."
            },
            "type": "ListItem",
            "sequence_num": 162
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Wholesalers who offer the greatest discount from list price are selected and allocated as the preferred supplier so as to maximize savings against discounted drug lines. These discounts are detailed in the East of England Collaborative Procurement Hub wholesaler framework."
            },
            "type": "ListItem",
            "sequence_num": 163
        },
        {
            "data": {
                "is_heading": 0,
                "text": "In the case of a non-contract line, the purchasing department compares purchase cost from all known suppliers and assign a preferred supplier based on a number of criteria such as individual product characteristics (e.g. labelling), cost, lead time and robustness of supply."
            },
            "type": "ListItem",
            "sequence_num": 164
        },
        {
            "data": {
                "is_heading": 1,
                "text": "b) Direct"
            },
            "type": "ListItem",
            "sequence_num": 165
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Orders for drugs not available via wholesalers are placed directly with manufacturers and distributors. The turnaround time (typically between 24 and 72 working hours) will be taken into account when considering stock holding and re-order frequency."
            },
            "type": "ListItem",
            "sequence_num": 166
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The pharmacy procurement system is used to derive values describing average use and turnaround times, and then apply these to a user defined order schedule (weekly / fortnightly or monthly). This will allow consolidation of orders to maximise order lines. In this way the frequency and size of orders to manufacturers and distributors is defined."
            },
            "type": "ListItem",
            "sequence_num": 167
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Orders placed with manufacturers and distributors are done so in accordance with this pre-defined schedule, vetted as above."
            },
            "type": "ListItem",
            "sequence_num": 168
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This process allows the pharmacy procurement team to maximise the number of lines per order to no less than 5 lines per order."
            },
            "type": "ListItem",
            "sequence_num": 169
        },
        {
            "data": {
                "is_heading": 1,
                "text": "c) Homecare"
            },
            "type": "ListItem",
            "sequence_num": 170
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Homecare is defined as a service that regularly delivers medicine supplies and associated care directly to a patient's choice of location. It does not include delivery to a hospital clinic or ward. Homecare services are split between those which are set up by the pharmaceutical industry for individual products and those services which are contracted to an NHS specification."
            },
            "type": "ListItem",
            "sequence_num": 171
        },
        {
            "data": {
                "is_heading": 0,
                "text": "There are different levels of Homecare services from simple dispensing and delivery of oral medicines (low tech) to more complex injectable aseptic preparations and the inclusion of nurse administration (high tech). These activities do not attract VAT and therefore represent a significant saving to the Trust, particularly in the provision of expensive drugs."
            },
            "type": "ListItem",
            "sequence_num": 172
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The use of a Homecare service does not reduce or alter the duty of care to patients. The Trust and patients clinical team retain responsibility for the clinical aspects of the patient's treatment."
            },
            "type": "ListItem",
            "sequence_num": 173
        },
        {
            "data": {
                "is_heading": 0,
                "text": "SLA's with the homecare providers ensure that areas of responsibility are clearly defined for all parties within the agreement."
            },
            "type": "ListItem",
            "sequence_num": 174
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All homecare services are subject to the Trust's medicine governance procedures including the Trust's medicines management policies and the Homecare procurement process will comply with the Trust's Standing Financial Instructions. Please refer to MSBPO-18021 MM Policy for Pharmacy Purchasing of Medicines via Homecare."
            },
            "type": "ListItem",
            "sequence_num": 175
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Only Homecare prescriptions that have been clinically screened and signed by a pharmacist are processed on the pharmacy procurement system."
            },
            "type": "ListItem",
            "sequence_num": 176
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where NHS contracts exist for medicines supplied under a Homecare service, the Homecare service will, wherever possible, be granted access to those contract prices."
            },
            "type": "ListItem",
            "sequence_num": 177
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.2,
                "text": "Receipt"
            },
            "type": "ListItem",
            "sequence_num": 178
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.2.1 All deliveries are checked and validated against raised orders, processed, and sent for storage in dispensary robot or pharmacy stores area on the day they are received, where possible, or as soon as possible thereafter. A procedure is required to cover all aspects of the receipt process including: product acceptance, items requiring special handling requirements and recording of batch numbers and expiry dates, e.g. controlled drugs."
            },
            "type": "ListItem",
            "sequence_num": 179
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.2.2 All delivery discrepancies are identified and processed by the pharmacy procurement team within 72 hours of receipt of order. This will include claims for missing / damaged goods, incorrect invoices and goods returns. There will be a process in place for the management of \u201cgoods ordered, not received\u201d to ensure:"
            },
            "type": "ListItem",
            "sequence_num": 180
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All orders are fulfilled in full or credits received;"
            },
            "type": "ListItem",
            "sequence_num": 181
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Alternative products are ordered where appropriate."
            },
            "type": "ListItem",
            "sequence_num": 182
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.2.3 To-follow items identified by suppliers, either at the time of ordering by electronic order confirmation or, at the time of delivery, are re-ordered from another approved supplier in order to ensure continuity of supply to patients."
            },
            "type": "ListItem",
            "sequence_num": 183
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.2.3 All supplier deliveries into pharmacy are undertaken in a timely manner, during working hours only and are checked by qualified pharmacy staff (senior stores person, their deputy, pharmacy assistant or technician) for accuracy against the relevant purchase order."
            },
            "type": "ListItem",
            "sequence_num": 184
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.2.4 All deliveries are signed for by qualified staff (senior stores person, their deputy, pharmacy assistant or technician) ensuring that the correct number of packages on the delivery note is received."
            },
            "type": "ListItem",
            "sequence_num": 185
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.2.5 Pharmacy staff need to be aware of the potential for counterfeit medicines to enter the supply and how potential issues need to be dealt with. In time, all sites will need to be compliant with the EU Falsified Medicines Directive (2011/62/EU) as, and when, the required IT systems are upgraded and locally required hardware becomes available."
            },
            "type": "ListItem",
            "sequence_num": 186
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.2.6 All controlled drug deliveries from suppliers or wholesalers are checked individually ensuring all products and quantities on the delivery note are actually"
            },
            "type": "ListItem",
            "sequence_num": 187
        },
        {
            "data": {
                "is_heading": 0,
                "text": "received before signing the delivery driver's delivery note."
            },
            "type": "ListItem",
            "sequence_num": 188
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.3,
                "text": "Storage (including security)"
            },
            "type": "ListItem",
            "sequence_num": 189
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.3.1 There are clear arrangements for the storage of medicines being delivered into the hospital pharmacy department or waiting onward transportation. These arrangements cover immediate receipt, storage until required for issue, dedicated quarantine areas, storage of medicines packed for transfer/collection."
            },
            "type": "ListItem",
            "sequence_num": 190
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.3.2 Items due for return to a supplier (damaged, delivered in error etc.) are also held \u201cin bond\u201d in a designated area. This stock is subject to the same storage and handling considerations that apply to all stock held within pharmacy. This includes ensuring that it is handled in a safe and secure manner i.e. access limited to appropriate staff, temperature mapped and controlled environment."
            },
            "type": "ListItem",
            "sequence_num": 191
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.4,
                "text": "Distribution/transportation"
            },
            "type": "ListItem",
            "sequence_num": 192
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.4.1 The internal supply chain for medicines must be robust with Trusts, including delivery, storage and onward delivery to patient areas. This movement of medicines complies with the \u2018Safe and Secure Handling of Medicines Guidance'."
            },
            "type": "ListItem",
            "sequence_num": 193
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.4.2 This guidance also applies to items intended for external distribution but additional considerations may apply such as:"
            },
            "type": "ListItem",
            "sequence_num": 194
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Security;"
            },
            "type": "ListItem",
            "sequence_num": 195
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Maintenance of cold-chain storage;"
            },
            "type": "ListItem",
            "sequence_num": 196
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Address/destination labelling;"
            },
            "type": "ListItem",
            "sequence_num": 197
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Required paperwork."
            },
            "type": "ListItem",
            "sequence_num": 198
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.5,
                "text": "Non-CMU contract purchases"
            },
            "type": "ListItem",
            "sequence_num": 199
        },
        {
            "data": {
                "is_heading": 1,
                "text": "8.5.1 Off-contract claims"
            },
            "type": "ListItem",
            "sequence_num": 200
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Wherever possible, items are purchased in line with the contracts put in place either by CMU or locally. Supply disruptions are not uncommon, however, and in these situations it may be necessary to purchase off-contract. There is a procedure in place for when on-contract purchases cannot be made. This includes the logging, tracking and pursuing of off-contract claims. This process is in line with CMU guidance. Products purchased off-contract are subject to local reviews and risk assessment to ensure they are safe and appropriate for use."
            },
            "type": "ListItem",
            "sequence_num": 201
        },
        {
            "data": {
                "is_heading": 1,
                "text": "8.5.2 Local Contracts"
            },
            "type": "ListItem",
            "sequence_num": 202
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.5.2.1 Drugs not included under a CMU contract are considered for a local contractual agreement. All local contracts are a written and signed agreement between Trust representatives (Regional Procurement Specialist Pharmacist or Lead Pharmacy Procurement Technician) and drug manufacturer / supplier, specifying the price and duration agreed. It is essential to comply with local SFIs and EU procurement legislation in these instances."
            },
            "type": "ListItem",
            "sequence_num": 203
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.5.2.2 In the case of a non-contract line, the procurement department compares purchase cost from all known suppliers and assigns a preferred supplier based on a number of criteria such as individual product characteristics (e.g. labelling), cost, lead time and robustness of supply."
            },
            "type": "ListItem",
            "sequence_num": 204
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.5.2.3 Further guidance is given by the \u2018Purchasing for Safety \u2013 Decision Making Tree' (Appendix 1)."
            },
            "type": "ListItem",
            "sequence_num": 205
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.6,
                "text": "Financial / Invoice Management"
            },
            "type": "ListItem",
            "sequence_num": 206
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.6.1 There is an accountable system for processing and recording invoices and credit notes. All invoices are checked for accuracy prior to clearance for payment and submitted to finance for payment within 72 hours. The system for authorising invoices for payment ensures that duplicate payments are avoided."
            },
            "type": "ListItem",
            "sequence_num": 207
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.6.2 Any invoice discrepancies are subject to investigation with the supplier, prior to clearance for payment, and if appropriate, credit and/or recharge requested. Payments are made only for goods and services which have been officially ordered and received."
            },
            "type": "ListItem",
            "sequence_num": 208
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.6.3 Any supplier that subscribes to electronic invoice payment is dealt with in this manner."
            },
            "type": "ListItem",
            "sequence_num": 209
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.6.4 A review of all outstanding (yet to be received) invoices is undertaken on a monthly basis by running the standard report within JAC/Ascribe."
            },
            "type": "ListItem",
            "sequence_num": 210
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.6.5 There is adequate segregation of duties so that no single individual can order, receive and certify an invoice (with the exception of Homecare). The person authorising a payment should also not be involved in the actual payment process."
            },
            "type": "ListItem",
            "sequence_num": 211
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Medication Error/Risk Reporting Systems"
            },
            "type": "ListItem",
            "sequence_num": 212
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "There is a departmental protocol for the handling and managing of alerts and recalls of medicines and medical devices. This document covers the receipt and following action required of MHRA drug alerts, company-led recalls, medical device alerts etc. Also covered is the process to be followed when reporting a potentially defective medicine or medical device."
            },
            "type": "ListItem",
            "sequence_num": 213
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "Appropriate records of actions taken in response to an alert or recall need to be maintained for auditing purposes."
            },
            "type": "ListItem",
            "sequence_num": 214
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.3,
                "text": "As well as reporting potential issues externally (see Appendix 2), the pharmacy procurement team will report any incidents or errors internally using the Trust's incident reporting systems as per hospital policy."
            },
            "type": "ListItem",
            "sequence_num": 215
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Shortages"
            },
            "type": "ListItem",
            "sequence_num": 216
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "The management of medicine supply disruptions and associated shortages is an essential task for the pharmacy procurement team and one that is taking an increasing proportion of staff time to manage effectively."
            },
            "type": "ListItem",
            "sequence_num": 217
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "There is a national document covering the management of shortages within the NHS (3)."
            },
            "type": "ListItem",
            "sequence_num": 218
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "A specific MSE group-wide SOP is in place to cover all aspects of the medicine shortages management process. This covers the internal processes required within pharmacy to ensure the correct steps are undertaken to manage and mitigate shortages as they arise. Also key is the process of escalation from the pharmacy procurement team to the clinical pharmacy team and then onto the patient facing areas where required. The effective communications associated with the escalation of these issues is essential. This is particularly true where the management of a particular shortage requires the:"
            },
            "type": "ListItem",
            "sequence_num": 219
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Introduction of a new product, or packaging, which staff are likely to be unfamiliar with;"
            },
            "type": "ListItem",
            "sequence_num": 220
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Utilisation of an alternative product/medicine which was previously a non- formulary item."
            },
            "type": "ListItem",
            "sequence_num": 221
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "Shortages with higher levels of risk are issued via the Central Alerting System as Supply Disruption Alerts. The departmental SOP outlines how the shortage should be handled."
            },
            "type": "ListItem",
            "sequence_num": 222
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.4,
                "text": "See also Change Management section below."
            },
            "type": "ListItem",
            "sequence_num": 223
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "New Product Process (Formulary management etc)"
            },
            "type": "ListItem",
            "sequence_num": 224
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "Drug files on JAC / Ascribe are only be amended by authorised staff i.e. lead pharmacy procurement technician and their deputy, the senior procurement clerk and the pharmacy IT systems manager (or equivalent). JAC / Ascribe user restrictions do not allow unauthorised access to this facility."
            },
            "type": "ListItem",
            "sequence_num": 225
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "A new medicine can only be added to the pharmacy system once the local \u201cnew drug request\u201d form has been completed. This includes unlicensed medicines, specials and parallel imports. Part of the new drug request process will include a risk assessment of the medicine. A separate SOP is required for each specific category of medicine e.g. injectables, specials, and compassionate use."
            },
            "type": "ListItem",
            "sequence_num": 226
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.3,
                "text": "New drug files are only created on JAC / Ascribe for medicines approved by the MOC (or equivalent); i.e. formulary approved medicines."
            },
            "type": "ListItem",
            "sequence_num": 227
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.4,
                "text": "Any request to order non-formulary (non- MOC, or equivalent) approved medicines is referred to the site clinical lead pharmacist for approval before addition to JAC/ Ascribe. This authorisation is documented in writing."
            },
            "type": "ListItem",
            "sequence_num": 228
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.5,
                "text": "The lead pharmacy procurement technician should be consulted before and after any request for a new medicine is submitted to the MOC (or equivalent). Issues such as product availability, cost, supply route and contract status need to be considered before a medicine is approved for addition to the hospital formulary."
            },
            "type": "ListItem",
            "sequence_num": 229
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.6,
                "text": "New drug files added to JAC / Ascribe will be assigned a preferred supplier. In the case of a contract line, this will be the contracted supplier."
            },
            "type": "ListItem",
            "sequence_num": 230
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.7,
                "text": "Sid4gov (https://sid4gov.cabinetoffice.gov.uk) is a national database of suppliers that hold, or have held, an NHS CMU contract for medicines or other products. Pharmacy QA and procurement staff can use this database to inspect, and assess, potential pharmaceutical suppliers."
            },
            "type": "ListItem",
            "sequence_num": 231
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Change Management Process"
            },
            "type": "ListItem",
            "sequence_num": 232
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "The site lead pharmacy procurement technician is responsible for coordinating local implementation of contract changes and this includes assessing the potential impact of these changes."
            },
            "type": "ListItem",
            "sequence_num": 233
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "Changes to NHS contracts such as price, contract termination or newly awarded tenders are overseen by the CMU who will aim to advise the local pharmacy procurement department of any such changes at least 1 month in advance of those changes taking effect in order that the pharmacy procurement system may be updated in time for contract start date."
            },
            "type": "ListItem",
            "sequence_num": 234
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.3,
                "text": "Where significant changes exist between the usual contract line and the newly awarded product, advice will be sought from the site clinical lead pharmacist and mse group Medicines Safety Officer. A decision will then be made on whether this is appropriate for use or whether risk mitigation processes are required e.g. product change poster."
            },
            "type": "ListItem",
            "sequence_num": 235
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.4,
                "text": "This change management process is to be deployed when other medicines enter the hospital for the first time such as when new products are added to the hospital formulary or a medicines shortage requires the temporary use of an alternative formulation or medicine. In each case, key staff (pharmacy, medical, nursing) will need to be made aware of significant changes to packaging, storage, and administration requirements."
            },
            "type": "ListItem",
            "sequence_num": 236
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Unlicensed Medicines"
            },
            "type": "ListItem",
            "sequence_num": 237
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "Wherever possible medicines licensed by the MHRA should be used."
            },
            "type": "ListItem",
            "sequence_num": 238
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "However, in some circumstances the use of a product not licensed in the UK or a product classified as a \u201cspecial\u201d may be required to meet patient need. MHRA guidance of the supply of specials is followed (reference 4)."
            },
            "type": "ListItem",
            "sequence_num": 239
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.3,
                "text": "An unlicensed medicine refers to a product that does not hold a UK marketing authorisation (previously known as a product license)."
            },
            "type": "ListItem",
            "sequence_num": 240
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.4,
                "text": "The marketing authorisation of a product guarantees the quality, safety and efficacy of a medicinal product and to some extent, places liability on the marketing authorisation holder for adverse effects arising from the use of their product. The same assumption cannot be made for unlicensed medicinal products."
            },
            "type": "ListItem",
            "sequence_num": 241
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.5,
                "text": "All procurement of unlicensed medicines (and specials) is done so in accordance with MSBPO-18017 Unlicensed Medicines Policy."
            },
            "type": "ListItem",
            "sequence_num": 242
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.5.1 This policy includes a risk assessment of the medicine involved to ensure potential risks are identified and possible mitigations put in place."
            },
            "type": "ListItem",
            "sequence_num": 243
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.5.2 The risk assessment includes how the medicine is ordered, stored and prescribed, as well as how the product will be introduced safely into the Trust."
            },
            "type": "ListItem",
            "sequence_num": 244
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.5.3 This follows the principles outlined in the change management process above."
            },
            "type": "ListItem",
            "sequence_num": 245
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.6,
                "text": "Unlicensed medicines should only be used where their use is clearly justified and their clinical / pharmaceutical benefits are considered to outweigh the risks involved."
            },
            "type": "ListItem",
            "sequence_num": 246
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.6.1 In certain circumstances unlicensed \u2018ready-to-use' or \u2018ready-to-administer' products may be safer than certain high risk, licensed, injectable products."
            },
            "type": "ListItem",
            "sequence_num": 247
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.6.2 These high risk medicines are assessed using the tool in NPSA Patient Safety Alert 20: Promoting safer use of injectable medicines."
            },
            "type": "ListItem",
            "sequence_num": 248
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.7,
                "text": "Junior medical staff should not initiate prescribing of unlicensed medicines without appropriate justification."
            },
            "type": "ListItem",
            "sequence_num": 249
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.8,
                "text": "All purchases of unlicensed medicines will be through QA approved suppliers and be subject to a robust QA process including risk assessment as specified in a pharmacy department procedure for sourcing and ordering unlicensed medicines."
            },
            "type": "ListItem",
            "sequence_num": 250
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.9,
                "text": "If an unlicensed medicine is substituted for a licensed one (e.g. in a shortage) the senior technician for information technology or the ePrescribing team (SUH site hosted) will be notified so the prescribing status of the medicine can be updated."
            },
            "type": "ListItem",
            "sequence_num": 251
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Monitoring and Review"
            },
            "type": "ListItem",
            "sequence_num": 252
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.1,
                "text": "Workload"
            },
            "type": "ListItem",
            "sequence_num": 253
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.1.2 The volume of work undertaken by the pharmacy procurement team is under regular review."
            },
            "type": "ListItem",
            "sequence_num": 254
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.1.3 The provision of the right medicine, at the right time and at the right cost, is vital for the effective functioning of the pharmacy department and the hospital in its entirety."
            },
            "type": "ListItem",
            "sequence_num": 255
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.1.4 The ability of the pharmacy procurement team to complete the key tasks that underpin the medicines supply process in a timely manner is essential."
            },
            "type": "ListItem",
            "sequence_num": 256
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.1.5 This requires regular tracking of workload statistics and markers of efficient process delivery."
            },
            "type": "ListItem",
            "sequence_num": 257
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.2,
                "text": "Procedures and SOPs"
            },
            "type": "ListItem",
            "sequence_num": 258
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.2.1 Processes within the pharmacy goods inwards area and procurement office follow agreed procedures as set out in the \u2018Pharmacy, Quality Assurance and Pharmacy Services Procedure' manuals."
            },
            "type": "ListItem",
            "sequence_num": 259
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.2.2 SOPs are reviewed when there is a change in practice or the review date is reached."
            },
            "type": "ListItem",
            "sequence_num": 260
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.2.3 Procedures (SOPs) detail in a step by step manner how processes are to be conducted within these areas and by whom."
            },
            "type": "ListItem",
            "sequence_num": 261
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.3,
                "text": "Supplier Performance"
            },
            "type": "ListItem",
            "sequence_num": 262
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.3.1 The pharmacy procurement team contributes data to support the regional KPI dashboards in place for the pharmaceutical wholesalers and homecare service providers."
            },
            "type": "ListItem",
            "sequence_num": 263
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.3.2 The management and oversight of individual suppliers of medicines awarded on CMU frameworks sits with the CMU itself."
            },
            "type": "ListItem",
            "sequence_num": 264
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Issues relating to any of these providers should immediately be escalated to CMU staff for investigation and follow up."
            },
            "type": "ListItem",
            "sequence_num": 265
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Issues relating to medicines or services tendered by the EoE Collaborative Procurement Hub are similarly escalated and dealt with."
            },
            "type": "ListItem",
            "sequence_num": 266
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Suppliers of medicines, products, or services that fall outside these arrangements should be liaised with at regular intervals in order to ensure service delivery to the required level and that any SLAs or KPIs in place are being met."
            },
            "type": "ListItem",
            "sequence_num": 267
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.4,
                "text": "Inventory Management"
            },
            "type": "ListItem",
            "sequence_num": 268
        },
        {
            "data": {
                "is_heading": 0,
                "text": "There is regular review (3-6 monthly) of the products held within pharmacy as outlined below in order to review usage and modify stock holdings accordingly. This aims to minimise the value of stock being wasted. This review of inventory includes:"
            },
            "type": "ListItem",
            "sequence_num": 269
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Product stock levels"
            },
            "type": "ListItem",
            "sequence_num": 270
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This requires a total stock take to occur once per year."
            },
            "type": "ListItem",
            "sequence_num": 271
        },
        {
            "data": {
                "is_heading": 1,
                "text": "The range of products held"
            },
            "type": "ListItem",
            "sequence_num": 272
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Any redundant product lines are identified. The continued requirement to keep these medicines in stock is reviewed with clinical colleagues."
            },
            "type": "ListItem",
            "sequence_num": 273
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Any slow moving lines held"
            },
            "type": "ListItem",
            "sequence_num": 274
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Any product where usage has declined is identified and attempts made to sell on any stock that is surplus to requirements. These products are also discussed with clinical colleagues."
            },
            "type": "ListItem",
            "sequence_num": 275
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Products due to expire"
            },
            "type": "ListItem",
            "sequence_num": 276
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Short dated products are identified and tracked. Once expired, these are removed from circulation. Their future requirement is reviewed before subsequent orders are placed. Expiry date checks occur regularly as per pharmacy departmental procedures."
            },
            "type": "ListItem",
            "sequence_num": 277
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Products wasted"
            },
            "type": "ListItem",
            "sequence_num": 278
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All wasted products are reviewed periodically to ensure any patterns or recurring themes are identified and lessons learned."
            },
            "type": "ListItem",
            "sequence_num": 279
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.5,
                "text": "Management Reports"
            },
            "type": "ListItem",
            "sequence_num": 280
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Key performance Indicators in the form of monthly management reports measure the following:"
            },
            "type": "ListItem",
            "sequence_num": 281
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Off contract purchases: The pharmacy department aims to make no off- contract purchases unless forced to do so through unavailability of contract lines. This can be checked against the contract variance report from CMU."
            },
            "type": "ListItem",
            "sequence_num": 282
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Waste through expiration or accidental damage of stock may be unavoidable but the pharmacy department aims to keep this value below 0.5% of the monthly drug spends."
            },
            "type": "ListItem",
            "sequence_num": 283
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Stock holding levels are monitored and tracked over time to detect unwarranted escalation."
            },
            "type": "ListItem",
            "sequence_num": 284
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Stock-turn is kept below 3 weeks with an ideal value between 2 and 2.5 weeks."
            },
            "type": "ListItem",
            "sequence_num": 285
        },
        {
            "data": {
                "is_heading": 1,
                "text": "E-trading and ordering stats. The level to which sites are trading electronically is monitored."
            },
            "type": "ListItem",
            "sequence_num": 286
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.6,
                "text": "KPI Data"
            },
            "type": "ListItem",
            "sequence_num": 287
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The pharmacy procurement team completes the national procurement KPIs on a monthly basis. This collates data relating to invoices, ordering, transactions, stock-holding etc. and allows benchmarked comparisons with other Trusts in the STP and regionally."
            },
            "type": "ListItem",
            "sequence_num": 288
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.7,
                "text": "Business Continuity Plans (BCP)"
            },
            "type": "ListItem",
            "sequence_num": 289
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Copies of The BCP for the pharmacy procurement & stores department are held in the pharmacy operations manager's office, the procurement office, QA department and the Chief Pharmacist's office (SUH site). The BCP sets out actions to be taken in the event of major incidents, pandemic, fire & flood, equipment failure, drug shortages, and staff shortages."
            },
            "type": "ListItem",
            "sequence_num": 290
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.7.1  It also contains a list of essential drugs and their quantities that must be ordered urgently and/or made available should contingency plans be invoked."
            },
            "type": "ListItem",
            "sequence_num": 291
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Training Requirements"
            },
            "type": "ListItem",
            "sequence_num": 292
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "Staff involved in the procurement, receipt, storage or distribution of medicines are trained according to the activities undertaken. This training covers, but is not limited to:"
            },
            "type": "ListItem",
            "sequence_num": 293
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The various SOPs relating to the pharmacy procurement function;"
            },
            "type": "ListItem",
            "sequence_num": 294
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The pharmacy IT systems in use;"
            },
            "type": "ListItem",
            "sequence_num": 295
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Pharmacy record keeping requirements;"
            },
            "type": "ListItem",
            "sequence_num": 296
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Good Distribution Practice guidance;"
            },
            "type": "ListItem",
            "sequence_num": 297
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Trust policies that impact on the procurement, receipt, storage or distribution of medicines e.g. SFIs, Health and Safety, Data Protection;"
            },
            "type": "ListItem",
            "sequence_num": 298
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National professional guidance e.g. Safe & Secure Handling of Medicines;"
            },
            "type": "ListItem",
            "sequence_num": 299
        },
        {
            "data": {
                "is_heading": 0,
                "text": "UK and EU procurement Law."
            },
            "type": "ListItem",
            "sequence_num": 300
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.2,
                "text": "New staff also require a procurement specific induction programme."
            },
            "type": "ListItem",
            "sequence_num": 301
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Monitoring and Audit"
            },
            "type": "ListItem",
            "sequence_num": 302
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Each document must outline the Trust's process of monitoring compliance with,"
            },
            "type": "ListItem",
            "sequence_num": 303
        },
        {
            "data": {
                "is_heading": 0,
                "text": "and the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 304
        },
        {
            "type": "table",
            "sequence_num": 305,
            "data": {
                "num_rows": 2,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Departmental KPIs"
                    },
                    {
                        "text": "Monthly Pharmacy Board Reports"
                    },
                    {
                        "text": "Pharmacy procurement department"
                    },
                    {
                        "text": "Monthly"
                    },
                    {
                        "text": "Pharmacy directorate Board"
                    },
                    {
                        "text": "Chief Pharmacist Medicines Optimisation Committee (or"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 306,
            "data": {
                "num_rows": 4,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "equivalent)"
                    },
                    {
                        "text": "National KPIs"
                    },
                    {
                        "text": "Monthly Procureme nt KPIs"
                    },
                    {
                        "text": "Pharmacy procurement department"
                    },
                    {
                        "text": "Monthly"
                    },
                    {
                        "text": "Pharmacy directorate Board"
                    },
                    {
                        "text": "Chief Pharmacist Medicines Optimisation Committee (or equivalent)"
                    },
                    {
                        "text": "Inventory Management"
                    },
                    {
                        "text": "Review of Key Indicators"
                    },
                    {
                        "text": "Pharmacy procurement department"
                    },
                    {
                        "text": "6 Monthly"
                    },
                    {
                        "text": "Pharmacy directorate Board"
                    },
                    {
                        "text": "Chief Pharmacist Medicines Optimisation Committee (or equivalent)"
                    },
                    {
                        "text": "Off-Contract Claim Management"
                    },
                    {
                        "text": "Review of Claims"
                    },
                    {
                        "text": "Pharmacy procurement department"
                    },
                    {
                        "text": "Monthly"
                    },
                    {
                        "text": "Pharmacy directorate Board"
                    },
                    {
                        "text": "Chief Pharmacist Medicines Optimisation Committee (or equivalent)"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Approval and Implementation"
            },
            "type": "ListItem",
            "sequence_num": 307
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This policy has been reviewed and approved by the Medicines Optimisation Committee (or equivalent), overseen by pharmacy, across the MSE group of hospitals. This will be implemented with immediate effect from its agreement date. This document will be available electronically on the Trust intranet. Advice and support on the implementation of this policy is available via the site Pharmacy Procurement Team within the department of pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 308
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Equality Impact Assessment"
            },
            "type": "ListItem",
            "sequence_num": 309
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This policy has been the subject of an Equality Impact Assessment. The output of the assessment demonstrates that no one as a consequence of this policy is placed at a disadvantage over others."
            },
            "type": "ListItem",
            "sequence_num": 310
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(Refer to Appendix 3)"
            },
            "type": "ListItem",
            "sequence_num": 311
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 312
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Royal Pharmaceutical Society (2018). Professional Guidance on the Safe and Secure Handling of Medicines (online). Available at: https://www.rpharms.com/recognition/setting-professional-standards/safe-and- secure-handling-of-medicines/professional-guidance-on-the-safe-and-secure- handling-of-medicines  [accessed 18/12/19]."
            },
            "type": "ListItem",
            "sequence_num": 313
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Committee on Standards in Public Life (1995). The 7 Principles of public life (online). Available at: https://www.gov.uk/government/publications/the-7- principles-of-public-life [accessed 18/12/19]."
            },
            "type": "ListItem",
            "sequence_num": 314
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NHS England (2019). A guide to managing medicines supply and shortages (online). Available at: https://www.england.nhs.uk/publication/a-guide-to- managing-medicines-supply-and-shortages/ [accessed 18/12/19]."
            },
            "type": "ListItem",
            "sequence_num": 315
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Medicines and Health Regulatory Authority (MHRA) (2014). The supply of unlicensed medicinal products (\u201cspecials\u201d) MHRA Guidance Note 14 (online). Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/att achment_data/file/373505/The_supply_of_unlicensed_medicinal_products__sp ecials_.pdf [accessed 18/12/19]."
            },
            "type": "ListItem",
            "sequence_num": 316
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: Purchasing for Safety Decision Making Tree"
            },
            "type": "ListItem",
            "sequence_num": 317
        },
        {
            "data": {
                "is_heading": 0,
                "text": "MEPA = PQA"
            },
            "type": "ListItem",
            "sequence_num": 318
        },
        {
            "type": "image",
            "sequence_num": 319,
            "data": {
                "url": "MSEPO-20203 Pharmacy Procurement of Medicines Policy 1.0.003.png"
            }
        },
        {
            "type": "image",
            "sequence_num": 320,
            "data": {
                "url": "MSEPO-20203 Pharmacy Procurement of Medicines Policy 1.0.004.jpeg"
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 2: Medication error, incident and defect reporting systems"
            },
            "type": "ListItem",
            "sequence_num": 321
        },
        {
            "type": "table",
            "sequence_num": 322,
            "data": {
                "num_rows": 12,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Reporting System"
                    },
                    {
                        "text": "When to Use"
                    },
                    {
                        "text": "Examples (not exhaustive list)"
                    },
                    {
                        "text": "Report Sent To"
                    },
                    {
                        "text": "Contact Information"
                    },
                    {
                        "text": "MHRA Defective Medicines Reporting Centre"
                    },
                    {
                        "text": "Suspected or actual product defect where patient safety clearly at risk. Guidance from the MHRA here http://www.mhra.gov.uk/home/g"
                    },
                    {
                        "text": "Serious unexpected reaction. Severe, visible microbial or particulate contamination. Suspected counterfeit product."
                    },
                    {
                        "text": "MHRA Defective Medicines Reporting Centre"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Quality Assurance Defect Reporting Scheme"
                    },
                    {
                        "text": "Product defects which are quality assurance in nature, with no immediate severe risk to patient safety. Defects reported to the MHRA should also be copied to CMU for contract lines."
                    },
                    {
                        "text": "Empty blister in strip. Missing batch number or expiry date, particulate contamination. Defective unlicensed medicines should also be reported."
                    },
                    {
                        "text": "Inform manufacturer. If necessary send sample to NHS Regional QA Service."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "ProMS (Potential Risk of Medication Selection)"
                    },
                    {
                        "text": "Incidents where products have been selected or supplied incorrectly, where issues relating to packaging design and presentation are felt to be contributory factors."
                    },
                    {
                        "text": "Selection of lookalike and sound-alike drugs. Manufacturer's packaging has poor differentiation between different products or strengths."
                    },
                    {
                        "text": "Send to an NHS Regional QA Service"
                    },
                    {
                        "text": "As for minor defects above. In addition these must be reported via the Trust incident reporting process via Datix"
                    },
                    {
                        "text": "CMU"
                    },
                    {
                        "text": "Issues relating to supply of medications purchased through CMU contracts."
                    },
                    {
                        "text": "Change in manufacturer of product supplied. Financial and contractual issues."
                    },
                    {
                        "text": "Relevant CMU buyer for Trust concerned."
                    },
                    {
                        "text": "See contact details for individual buyers. https://www.gov.uk/gov"
                    },
                    {
                        "text": "ernment/collections/co"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Pharmacy Procurement of Medicines Policy / MSEPO20203 / 1.0"
            },
            "type": "ListItem",
            "sequence_num": 323
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 27.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 324
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This is an uncontrolled copy of this policy. To check if this is a copy of the latest version please view this policy on-line on StaffNet"
            },
            "type": "ListItem",
            "sequence_num": 325
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Pharmacy Procurement of Medicines Policy / MSEPO20203 / 1.0"
            },
            "type": "ListItem",
            "sequence_num": 326
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 3: Preliminary Equality Analysis"
            },
            "type": "ListItem",
            "sequence_num": 327
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Pharmacy Procurement of Medicines Policy/ MSEPO20203"
            },
            "type": "ListItem",
            "sequence_num": 328
        },
        {
            "type": "table",
            "sequence_num": 329,
            "data": {
                "num_rows": 9,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "A change in a service to patients"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A change to an existing policy"
                    },
                    {
                        "text": "Y"
                    },
                    {
                        "text": "A change to the way staff work"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A new policy"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "No change to existing processes. Additional clarity added to policy in line with national guidance."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "Moving policy from SUH site to mse-wide application"
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Consistency across all sites within mse-group"
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No \u2013 nil change to current processes"
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change? b) If so, with whom?"
                    },
                    {
                        "text": "Yes Refer to pages 1 & 2"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Preliminary analysis completed by:"
            },
            "type": "ListItem",
            "sequence_num": 330
        },
        {
            "type": "table",
            "sequence_num": 331,
            "data": {
                "num_rows": 1,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Medication Safety Officer"
                    },
                    {
                        "text": "Date"
                    },
                    {
                        "text": "18/12/19"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 26.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 332
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This is an uncontrolled copy of this policy. To check if this is a copy of the latest version please view this policy on-line on StaffNet"
            },
            "type": "ListItem",
            "sequence_num": 333
        }
    ]
}